Erythrasma natural history, complications and prognosis: Difference between revisions
Irfan Dotani (talk | contribs) No edit summary |
mNo edit summary |
||
| (7 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Erythrasma}} | {{Erythrasma}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{LRO}} | ||
==Overview== | |||
Upon ''[[corynebacteria|Corynebacterium minitissium]]'' infection, the affected region of the [[epidermis]] becomes [[erythema|erythematous]] and present with [[pruritus]]. As [[hyperkeratosis]] and keratolysis occurs, the red-pink [[lesions]] becomes reddish-brown and begins to scale and shed. Without treatment, the [[lesions]] usually remain and spreading occurs concurrent with the spread of [[bacterial]] infection. Complications of erythrasma result from persistence of symptoms or spread of infection. Without treatment, the prognosis for erythrasma varies based on the emergence and presence of complications. With treatment, the prognosis for erythrasma is good; complete resolution of symptoms and recovery is expected. | |||
== | ==Natural History== | ||
*Upon ''[[corynebacteria|Corynebacterium minitissium]]'' infection, the affected region of the [[epidermis]] becomes [[erythema|erythematous]] and present with [[pruritus]].<ref name="BurnsBreathnach2010">{{cite book|author1=Tony Burns|author2=Stephen Breathnach|author3=Neil Cox|author4=Christopher Griffiths|title=Rook's Textbook of Dermatology|url=https://books.google.com/books?id=kcIOcR8Qm2gC&pg=SA5-PA19|accessdate=14 November 2010|year=2010|publisher=John Wiley and Sons|isbn=978-1-4051-6169-5|pages=5–}}</ref> | |||
*As [[hyperkeratosis]] and keratolysis occurs, the red-pink [[lesions]] becomes reddish-brown and begins to scale and shed. | |||
*Without treatment, the [[lesions]] usually remain and spreading occurs concurrent with the spread of [[bacterial]] infection. | |||
==Complications== | |||
Complications of erythrasma result from persistence of symptoms or spread of infection:<ref name="pmid18558055">{{cite journal |vauthors=Morales-Trujillo ML, Arenas R, Arroyo S |title=[Interdigital erythrasma: clinical, epidemiologic, and microbiologic findings] |language=Spanish; Castilian |journal=Actas Dermosifiliogr |volume=99 |issue=6 |pages=469–73 |year=2008 |pmid=18558055 |doi= |url=}}</ref> | |||
*[[Septicemia]] | |||
*[[Contact dermatitis]] | |||
*[[Lichenification]] if [[lesions]] are persistently scratched | |||
*[[Pigmentation]] scarring and disfiguration | |||
*[[Dermatophytosis]] and [[bacterial]] co-infections | |||
== | ==Prognosis== | ||
*Without treatment, the prognosis for erythrasma varies.<ref name="pmid18558055">{{cite journal |vauthors=Morales-Trujillo ML, Arenas R, Arroyo S |title=[Interdigital erythrasma: clinical, epidemiologic, and microbiologic findings] |language=Spanish; Castilian |journal=Actas Dermosifiliogr |volume=99 |issue=6 |pages=469–73 |year=2008 |pmid=18558055 |doi= |url=}}</ref> | |||
**The condition is usually chronic and recurrent if the ''[[corynebacterium|Corynebacterium minitissium]]'' infection is not treated. | |||
**Potential complications of infection, such as [[septicemia]], can lead to poor prognosis. | |||
*With treatment, the prognosis for erythrasma is good; complete resolution of symptoms and recovery is expected. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Latest revision as of 20:57, 9 November 2016
|
Erythrasma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Erythrasma natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Erythrasma natural history, complications and prognosis |
|
FDA on Erythrasma natural history, complications and prognosis |
|
Erythrasma natural history, complications and prognosis in the news |
|
Blogs on Erythrasma natural history, complications and prognosis |
|
Risk calculators and risk factors for Erythrasma natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.
Overview
Upon Corynebacterium minitissium infection, the affected region of the epidermis becomes erythematous and present with pruritus. As hyperkeratosis and keratolysis occurs, the red-pink lesions becomes reddish-brown and begins to scale and shed. Without treatment, the lesions usually remain and spreading occurs concurrent with the spread of bacterial infection. Complications of erythrasma result from persistence of symptoms or spread of infection. Without treatment, the prognosis for erythrasma varies based on the emergence and presence of complications. With treatment, the prognosis for erythrasma is good; complete resolution of symptoms and recovery is expected.
Natural History
- Upon Corynebacterium minitissium infection, the affected region of the epidermis becomes erythematous and present with pruritus.[1]
- As hyperkeratosis and keratolysis occurs, the red-pink lesions becomes reddish-brown and begins to scale and shed.
- Without treatment, the lesions usually remain and spreading occurs concurrent with the spread of bacterial infection.
Complications
Complications of erythrasma result from persistence of symptoms or spread of infection:[2]
- Septicemia
- Contact dermatitis
- Lichenification if lesions are persistently scratched
- Pigmentation scarring and disfiguration
- Dermatophytosis and bacterial co-infections
Prognosis
- Without treatment, the prognosis for erythrasma varies.[2]
- The condition is usually chronic and recurrent if the Corynebacterium minitissium infection is not treated.
- Potential complications of infection, such as septicemia, can lead to poor prognosis.
- With treatment, the prognosis for erythrasma is good; complete resolution of symptoms and recovery is expected.
References
- ↑ Tony Burns; Stephen Breathnach; Neil Cox; Christopher Griffiths (2010). Rook's Textbook of Dermatology. John Wiley and Sons. pp. 5–. ISBN 978-1-4051-6169-5. Retrieved 14 November 2010.
- ↑ 2.0 2.1 Morales-Trujillo ML, Arenas R, Arroyo S (2008). "[Interdigital erythrasma: clinical, epidemiologic, and microbiologic findings]". Actas Dermosifiliogr (in Spanish; Castilian). 99 (6): 469–73. PMID 18558055.